Maastricht, Netherlands · Founded 2016 · Privately Held (backing)
Developer of a tissue engineering technology designed for novel therapeutic options for vascular surgery. CuroTis is based in Maastricht, Netherlands and was founded in 2016. Its last reported valuation was $15.7 million in Jan 2025. It has raised $4.4 million.
Last reported valuation
$15.7M
Oct 2026
Priced at
—
Total raised
$4.4M
Last round
—
Team — not yet on record
No current team members for CuroTis are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CuroTis with a free account
·Watch CuroTis: the Monday email on marks, rounds and moves
